PubMed COVID-19 Clinical Care

Sensitive detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein (S protein) is of significant clinical importance in the diagnosis of COVID-19 pandemic. In this work, a surface molecularly imprinted (SMI)

CONCLUSIONS: Rotavirus and meningococcal B were the most recommended OVs. About half of the physicians participating in the study stated that they did not have sufficient knowledge about OVs. Physicians with sufficient knowledge of OVs recommend OVs

CONCLUSION: In conclusion, the prevalence of chemosensory dysfunction symptoms, both olfactory and gustatory, after COVID-19 infection among the Saudi population was high. However, several factors can influence their duration, including gender

For an infectious disease such as COVID-19, we present a new four-stage vaccination model (unvaccinated, dose 1 + 2, booster, repeated boosters), which examines the impact of vaccination coverage, vaccination rate, generation interval, control

CONCLUSION: Our results indicated that the new case long-term trends were random on a global scale and stable within most countries; therefore, the virus was unlikely to be eliminated but containable. Policymakers are currently in the process of

CONCLUSION: Our study suggests that online-based distance learning in Arab countries still needs more improvement as students still are more inclined toward face-to-face teaching. However, exploring the factors that influence students' perceptions of

No abstract

CONCLUSIONS: Threshold tracking technique can be applied directly to small fibers via a psychophysical readout, but with the current technique, the reliability is poor.

CONCLUSIONS: The MCDA process has not been capitalised on in healthcare decision-making in India and LMICs. Considering the available data and stakeholder preference at the time of the study, Covaxin, Janssen, and Sputnik were preferred options. The

Cannabidiol (CBD) has a number of biological effects by acting on the cannabinoid receptors CB(1) and CB(2). CBD may be involved in anti-inflammatory processes via CB(1) and CB(2) receptors, resulting in a decrease of pro-inflammatory cytokines